Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Clinical Study

Magnetic Resonance Imaging of Implanted Deep Brain Stimulators: Experience in a Large Series

Larson P.S.a · Richardson R.M.a · Starr P.A.a · Martin A.J.b

Author affiliations

Departments of aNeurological Surgery and bRadiology, University of California, San Francisco, Calif., USA

Related Articles for ""

Stereotact Funct Neurosurg 2008;86:92–100

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Clinical Study

Published online: December 12, 2007
Issue release date: March 2008

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 3

ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)

For additional information: https://www.karger.com/SFN

Abstract

Magnetic resonance imaging (MRI) is a commonly used and important imaging modality to evaluate lead location and rule out complications after deep brain stimulation (DBS) surgery. Recent safety concerns have prompted new safety recommendations for the use of MRI in these patients, including a new recommendation to limit the specific absorption rate (SAR) of the MRI sequences used to less than 0.1 W/kg. Following SAR recommendations in real-world situations is problematic for a variety of reasons. We review our experience scanning patients with implanted DBS systems over a 7-year period using a variety of scanning techniques and four scanning platforms. 405 patients with 746 implanted DBS systems were imaged using 1.5-tesla MRI with an SAR of up to 3 W/kg. Many of the DBS systems were imaged multiple times, for a total of 1,071 MRI events in this group of patients with no adverse events. This series strongly suggests that the 0.1 W/kg recommendation for SAR may be unnecessarily low for the prevention of MRI-related adverse events.

© 2007 S. Karger AG, Basel


References

  1. Tisch S, Zrinzo L, Limousin P, Bhatia KP, Quinn N, Ashkan K, Hariz M: The effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalised dystonia. J Neurol Neurosurg Psychiatry, in press.
  2. Pinto S, Le Bas JF, Castana L, Krack P, Pollak P, Benabid AL: Comparison of two techniques to postoperatively localize the electrode contacts used for subthalamic nucleus stimulation. Neurosurgery 2007;60:285–292.
  3. Vergani F, Landi A, Antonini A, Parolin M, Cilia R, Grimaldi M, Ferrarese C, Gaini SM, Sganzerla EP: Anatomical identification of active contacts in subthalamic deep brain stimulation. Surg Neurol 2007;67:140–147.
  4. Pollo C, Vingerhoets F, Pralong E, Ghika J, Maeder P, Meuli R, Thiran JP, Villemure JG: Localization of electrodes in the subthalamic nucleus on magnetic resonance imaging. J Neurosurg 2007;106:36–44.
  5. Arantes PR, Cardoso EF, Barreiros MA, Teixeira MJ, Goncalves MR, Barbosa ER, Sukwinder SS, Leite CC, Amaro E Jr: Performing functional magnetic resonance imaging in patients with Parkinson’s disease treated with deep brain stimulation. Mov Disord 2006;21:1154–1162.
  6. Ondo WG, Bronte-Stewart H: The North American survey of placement and adjustment strategies for deep brain stimulation. Stereotact Funct Neurosurg 2005;83:142–147.
  7. Hamid NA, Mitchell RD, Mocroft P, Westby GW, Milner J, Pall H: Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement. J Neurol Neurosurg Psychiatry 2005;76:409–414.
  8. Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ Jr: Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002;97:370–387.
  9. Ryu SI, Romanelli P, Heit G: Asymptomatic transient MRI signal changes after unilateral deep brain stimulation electrode implantation for movement disorder. Stereotact Funct Neurosurg 2004;82:65–69.
  10. Henderson JM, Tkach J, Phillips M, Baker K, Shellock FG, Rezai AR: Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson’s disease: case report. Neurosurgery 2005;57:E1063.
  11. Spiegel J, Fuss G, Backens M, Reith W, Magnus T, Becker G, Moringlane JR, Dillmann U: Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report. J Neurosurg 2003;99:772–774.
  12. Tremmel J (ed): Urgent Device Correction – Change of Safe Limits for MRI Procedures Used with Medtronic Activa Deep Brain Stimulation Systems. Medtronic, 2005.
  13. Baker KB, Tkach JA, Phillips MD, Rezai AR: Variability in RF-induced heating of a deep brain stimulation implant across MR systems. J Magn Reson Imaging 2006;24:1236–1242.
  14. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001;345:956–963.
  15. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP: Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson’s disease: results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375–1382.
  16. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N: Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240–2249.
  17. Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R: Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord 2001;16:464–468.
  18. Lee JY, Kondziolka D: Thalamic deep brain stimulation for management of essential tremor. J Neurosurg 2005;103:400–403.
  19. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA: Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery 2004;54:1120–1130.
  20. Putzke JD, Wharen RE Jr, Obwegeser AA, Wszolek ZK, Lucas JA, Turk MF, Uitti RJ: Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis. Can J Neurol Sci 2004;31:333–342.
  21. Kupsch A, Benecke R, Muller J, Trottenberg T, Schneider GH, Poewe W, Eisner W, Wolters A, Muller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J: Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978–1990.
  22. Starr PA, Turner RS, Rau G, Lindsey N, Heath S, Volz M, Ostrem JL, Marks WJ Jr: Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. Neurosurg Focus 2004;17:E4.
  23. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tezenas du Montcel S, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, Destee A, Pollak P: Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459–467.
  24. Krempien RC, Daeuber S, Hensley FW, Wannenmacher M, Harms W: Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Brachytherapy 2003;2:164–171.
  25. Ferroli P, Franzini A, Marras C, Maccagnano E, D’Incerti L, Broggi G: A simple method to assess accuracy of deep brain stimulation electrode placement: pre-operative stereotactic CT + postoperative MR image fusion. Stereotact Funct Neurosurg 2004;82:14–19.
  26. Duffner F, Schiffbauer H, Breit S, Friese S, Freudenstein D: Relevance of image fusion for target point determination in functional neurosurgery. Acta Neurochir (Wien) 2002;144:445–451.
  27. Rezai AR, Finelli D, Nyenhuis JA, Hrdlicka G, Tkach J, Sharan A, Rugieri P, Stypulkowski PH, Shellock FG: Neurostimulation systems for deep brain stimulation: in vitro evaluation of magnetic resonance imaging-related heating at 1.5 Tesla. J Magn Reson Imaging 2002;15:241–250.
  28. Liem LA, van Dongen VC: Magnetic resonance imaging and spinal cord stimulation systems. Pain 1997;70:95–97.
  29. Shinbane JS, Colletti PM, Shellock FG: MR in patients with pacemakers and ICDs: defining the issues. J Cardiovasc Magn Reson 2007;9:5–13.
  30. Georgi JC, Stippich C, Tronnier VM, Heiland S: Active deep brain stimulation during MRI: a feasibility study. Magn Reson Med 2004;51:380–388.
  31. Finelli DA, Rezai AR, Ruggieri PM, Tkach JA, Nyenhuis JA, Hrdlicka G, Sharan A, Gonzalez-Martinez J, Stypulkowski PH, Shellock FG: MR imaging-related heating of deep brain stimulation electrodes: in vitro study. AJNR Am J Neuroradiol 2002;23:1795–1802.
  32. Rezai AR, Finelli D, Rugieri P, Tkach J, Nyenhuis JA, Shellock FG: Neurostimulators: potential for excessive heating of deep brain stimulation electrodes during magnetic resonance imaging. J Magn Reson Imaging 2001;14:488–489.
  33. Shellock FG, Cosendai G, Park SM, Nyenhuis JA: Implantable microstimulator: magnetic resonance safety at 1.5 Tesla. Invest Radiol 2004;39:591–599.
  34. Schaefer DJ: Safety aspects of radiofrequency power deposition in magnetic resonance. Magn Reson Imaging Clin N Am 1998;6:775–789.
  35. Schueler BA, Parrish TB, Lin JC, Hammer BE, Pangrle BJ, Ritenour ER, Kucharczyk J, Truwit CL: MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging 1999;9:596–603.
  36. Sawyer-Glover AM, Shellock FG: Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices. J Magn Reson Imaging 2000;12:92–106.
  37. Heistad DD, Abboud FM: Factors that influence blood flow in skeletal muscle and skin. Anesthesiology 1974;41:139–156.
  38. Medtronic: MRI Guidelines for DBS. Medtronic, 2006.
  39. FDA: Adverse Event Report: Med Rel, Inc Soletra IPG. FDA, 2003.
  40. Kovacs N, Nagy F, Kover F, Feldmann A, Llumiguano C, Janszky J, Kotek G, Doczi T, Balas I: Implanted deep brain stimulator and 1.0-Tesla magnetic resonance imaging. J Magn Reson Imaging 2006;24:1409–1412.
  41. Tronnier VM, Staubert A, Hahnel S, Sarem-Aslani A: Magnetic resonance imaging with implanted neurostimulators: an in vitro and in vivo study. Neurosurgery 1999;44:118–125.
  42. Rezai AR, Phillips M, Baker KB, Sharan AD, Nyenhuis J, Tkach J, Henderson J, Shellock FG: Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow safety recommendations. Invest Radiol 2004;39:300–303.
  43. Nitz WR, Brinker G, Diehl D, Frese G: Specific absorption rate as a poor indicator of magnetic resonance-related implant heating. Invest Radiol 2005;40:773–776.

Article / Publication Details

First-Page Preview
Abstract of Clinical Study

Published online: December 12, 2007
Issue release date: March 2008

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 3

ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)

For additional information: https://www.karger.com/SFN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.